U.S. Basic Materials Stock News

Live Oak Bancshares (LOB) just passed a key milestone, crossing $10 billion in assets and appointing seasoned risk executive Ewa M. Stasiowska as its dedicated Chief Risk Officer. This move separates the role from general counsel. See our latest analysis for Live Oak Bancshares. The leadership reshuffle and the $10 billion asset milestone come after a choppy stretch, with a 30 day share price return of 5.35% but a 1 year total shareholder return of minus 28.94%, suggesting sentiment is...

In November 2025, Appian and Ignyte Group’s “Bring AI to Work(flow)” solution was named a Pioneer in Healthcare Innovation and winner of the HL7 AI Challenge for advancing health data interoperability and ethical AI using the Appian Platform and HL7 FHIR standards. The recognition highlights how Appian’s process automation and data fabric can embed multiple forms of AI directly into clinical and operational workflows, reinforcing its relevance for government agencies and healthcare systems...

Marvell Technology (MRVL) has turned in a punchy Q3 2026 print, with revenue of about $2.1 billion and basic EPS of $2.22, while net income (excluding extra items) came in at $1.9 billion as the latest marker of its profitability turnaround. The company has seen revenue move from $1.52 billion in Q3 2025 to $2.07 billion in Q3 2026 alongside a swing in net income from a loss of $676.3 million to a $1.9 billion profit, setting up a quarter where margins look materially healthier and far more...

Golar LNG (GLNG) has quietly drifted lower over the past month even as its long term track record and growing earnings suggest a more nuanced story for patient investors. See our latest analysis for Golar LNG. Despite the recent 30 day share price return of negative 7.35 percent and year to date share price return of negative 12.89 percent, Golar LNG is still coming off a powerful three year total shareholder return of 74.18 percent and a five year total shareholder return of 352.61 percent...

Luckin Coffee (OTCPK:LKNC.Y) has been quietly rewarding patient investors, with the stock up roughly 49% over the past year even as it dipped about 10% over the past month. See our latest analysis for Luckin Coffee. That recent pullback in the share price, including a 1 month share price return of around negative 10 percent, sits against a strong backdrop of roughly 49 percent 1 year total shareholder return. This suggests momentum is pausing rather than breaking. If Luckin’s run has you...

UP Fintech Holding recently announced it would release its quarterly earnings on December 4, 2025, with analysts estimating earnings per share of US$0.21. The earnings update is especially important because the market is looking for clues on management’s guidance and how it aligns with existing growth expectations. With the earnings release expected to shed light on guidance, we’ll now examine what this could mean for UP Fintech’s investment narrative. These 10 companies survived and thrived...

The recent pop in Prudential Financial (PRU) appears tied less to a single headline and more to a cluster of signals, including a planned CIO transition and visible momentum inside its Prudential Advisors unit. See our latest analysis for Prudential Financial. Those moves come at a time when Prudential Financial’s share price, now around $109.57, has delivered a solid five year total shareholder return of 73.84%. This has occurred even as this year’s share price return is still in negative...

ACADIA Pharmaceuticals recently presented at Citi’s Annual Global Healthcare Conference 2025 in Miami, highlighting its progress in central nervous system and rare disease therapies. Stronger-than-expected third-quarter earnings and analyst commentary on Nuplazid and Daybue’s commercial traction have sharpened investor focus on ACADIA’s growth profile. Now we’ll examine how ACADIA’s earnings beat and evolving analyst views may shape the company’s broader investment narrative. The best AI...

Macy's (M) just turned in another steady quarter, with Q2 2026 revenue of about $5.0 billion, basic EPS of $0.32, and net income of $87 million setting the tone for its upcoming Q3 2026 readout. Over the last few quarters the top line has hovered around the $4.8 billion to $5.1 billion range while EPS moved from $0.10 in Q3 2025 to $0.14 in Q1 2026 and then to $0.32 in Q2 2026, giving investors a clearer view of how profitability is tracking through the cycle. With trailing 12 month EPS at...

Zeta Global Holdings (ZETA) just raised its revenue outlook for late 2025 and through 2026, leaning on accelerated growth and fresh contribution from Marigold’s enterprise software unit to support that trajectory. See our latest analysis for Zeta Global Holdings. The stronger guidance appears to have nudged sentiment, with the 1 day share price return of 3.9% lifting Zeta to $18.39. However, its 1 year total shareholder return is still down sharply, even after a robust three year total...

If you have ever wondered whether Illinois Tool Works at around $250 a share is quietly turning into a value opportunity or just clinging to a premium price tag, you are exactly who this breakdown is for. The stock is roughly flat year to date, up 0.4% over the last week and 2.8% over the last month, but still down about 7.1% over the past year even after delivering a solid 21.8% gain over 3 years and 35.8% over 5 years. That mixed performance has come as investors weigh ITW's position as a...

Janux Therapeutics recently reported positive updated interim Phase 1 data for its PSMA-directed TRACTr candidate JANX007 in metastatic castration-resistant prostate cancer, based on 109 treated patients as of the October 15, 2025 cutoff, and held a virtual event on December 1 to discuss the results. The update highlights not only progress for JANX007 but also reinforces Janux’s broader TRACTr and ARM platforms, which span multiple solid tumors and an emerging CD19 program in autoimmune...

Yuanbao (YB) just posted Q2 2025 results with revenue of CNY 1.1 billion and net income of CNY 983.9 million, translating to basic EPS of CNY 27.33 as the company continues to build on its recent move into solid profitability. The company has seen revenue move from CNY 854.5 million and net income of CNY 106.4 million in Q2 2024 to CNY 1.1 billion and CNY 983.9 million in Q2 2025, while trailing twelve month EPS has climbed from a loss of CNY 0.20 per share a year ago to CNY 69.96,...

Asana (ASAN) just posted its Q3 2026 numbers, with revenue at about $201 million and basic EPS at roughly -$0.29. This keeps the focus firmly on how quickly the business can convert top line scale into a path toward profitability. The company has seen revenue move from around $179 million in Q2 2025 to roughly $201 million in Q3 2026, while basic EPS over that span has hovered between about -$0.31 and -$0.17. That sets up this quarter as another check in on whether margins are starting to...

Why Apple Stock Is Back in Focus Apple (AAPL) has quietly outpaced the broader market over the past 3 months, climbing about 19%, and that steady move higher is drawing fresh attention from investors comparing today’s price to longer term returns. See our latest analysis for Apple. After a choppy year, Apple’s recent 30 day share price return of 5.65%, on top of a 16.57% year to date share price gain and a 17.50% one year total shareholder return, suggests bullish momentum is rebuilding as...

Q2 Holdings (QTWO) is back in the spotlight after solid quarterly results and a higher full year outlook, which have collided with some nagging issues, including elevated churn and softer annual recurring revenue growth. See our latest analysis for Q2 Holdings. The stock has bounced recently, with a 1 month share price return of nearly 17 percent off its lows. However, that follows a steep year to date share price decline and a weak 1 year total shareholder return, suggesting momentum is only...

Wondering if Expedia Group is still a good deal after its big run up, or if you have already missed the value story? This breakdown is going to walk through what the market might be pricing in and what it could be overlooking. The stock has climbed 1.9% over the last week, 21.7% over the past month, and is now up 41.6% year to date, building on a 40.5% gain over the past year and a 191.4% move in three years. Recent headlines have focused on Expedia's ongoing push to streamline its brands...

United Parcel Service (UPS) has quietly staged a rebound, with shares up about 4% over the past month and roughly 16% in the past 3 months, even as the 1 year return remains negative. See our latest analysis for United Parcel Service. That recent upswing in the share price, now around $98.21, suggests sentiment is stabilising after a tough stretch, with short term share price momentum improving even as the 1 year total shareholder return remains firmly negative. If UPS has you rethinking the...

GXO Logistics (GXO) just moved to sharpen its balance sheet, tweaking key leverage covenants to net more cash and locking in €500 million of 3.75% senior notes in its first European bond deal. See our latest analysis for GXO Logistics. The financing moves come after a choppy stretch, with a 30 day share price return of negative 9.32% but an 18.34% share price return year to date and a 17.44% three year total shareholder return. This suggests improving momentum despite more muted recent...

Sterling Infrastructure recently highlighted strong demand across mission-critical markets such as data centers, e-commerce, and manufacturing, alongside its completed acquisition of CEC Facilities Group, which enhances its electrical services capabilities and supports longer-term project visibility through an expanded backlog and pipeline. An interesting angle for investors is how CEC’s integration could shift Sterling’s earnings mix toward higher-value, electrical-heavy work with potential...

Tarsus Pharmaceuticals (TARS) has quietly rewarded patient shareholders, with the stock up about 59% over the past year and more than quadrupling over three years, despite ongoing net losses. See our latest analysis for Tarsus Pharmaceuticals. That kind of move, with a recent 30 day share price return of about 17% and a one year total shareholder return nearing 59%, suggests momentum is building as investors reassess Tarsus Pharmaceuticals’ growth prospects against its still loss making...

On December 1, 2025, CoreCivic amended its credit agreement, expanding its revolving credit facility by US$300 million to US$575 million within a US$700 million overall facility, while also preserving existing pricing and maturities through October 11, 2028. Coupled with 18.1% year-on-year revenue growth to US$580.4 million and new government contract awards, the enlarged facility underscores management’s focus on liquidity to support upcoming occupancy ramp-ups and related start-up...

Commvault announced it will showcase its latest cyber resilience and AI-enabled recovery innovations, including Synthetic Recovery and Identity Resilience, at the Gartner IOCS Conference 2025 and recently secured the AWS Resilience Competency with an expanded multi-product listing in the AWS Marketplace. Together, these milestones highlight growing recognition of Commvault Cloud’s AI-driven protection and recovery capabilities across hybrid and multi-cloud environments, especially for...

Li Auto (NasdaqGS:LI) just posted November deliveries of 33,181 vehicles, extending its year over year slump and highlighting how margin pressure, higher costs and production hiccups are weighing on sentiment around the stock. See our latest analysis for Li Auto. That softer November delivery print sits against a weak backdrop, with a roughly 11.6 percent 1 month share price return and about 24.7 percent year to date share price return both in negative territory. The 1 year total shareholder...